[go: up one dir, main page]

BR9810017A - Derivado de 3--substituìdo 3,4-diidrotieno [2, 3d] pirimidina, e, uso do mesmo - Google Patents

Derivado de 3--substituìdo 3,4-diidrotieno [2, 3d] pirimidina, e, uso do mesmo

Info

Publication number
BR9810017A
BR9810017A BR9810017-3A BR9810017A BR9810017A BR 9810017 A BR9810017 A BR 9810017A BR 9810017 A BR9810017 A BR 9810017A BR 9810017 A BR9810017 A BR 9810017A
Authority
BR
Brazil
Prior art keywords
substituted
pyrimidine
groups
atom
dihydrothieno
Prior art date
Application number
BR9810017-3A
Other languages
English (en)
Inventor
Gerd Steiner
Uta Holzenkamp
Dorothea Starck
Alfred Bach
Karsten Wicke
Hans-Jurge Teschendorf
Francisco Javier Garcia-Ladona
Franz Emling
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of BR9810017A publication Critical patent/BR9810017A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"DERIVADO DE 3-SUBSTITUìDO 3,4-DIIDROTIENO[2, 3D]PIRIMIDINA, E, USO DO MESMO". A invenção refere-se a derivados de 3-substituído 3,4 diidrotieno[2, 3-d]pirimidina de fórmula I em que R¹ e R² significam um átomo de hidrogênio ou um grupo alquila C~ 1~-C~ 4~, R³ representa um grupo fenila, piridila, pirimidinila ou pirazinila opcionalmente mono- ou di-substituído por átomos de halogênio ou grupos C~ 1~-C~ 4~-alquila, trifluorometila, trifluorometoxi, hidroxila, C~ 1~-C~ 4~ alcoxi, amino, monometilamino, dimetilamino, ciano ou nitro, os referidos grupos podendo opcionalmente ser fundidos a um núcleo benzênico que é opcionalmente mono- ou di-substituído por átomos de halogênio ou grupos C~ 1~-C~ 4~-alquila, hidroxila, trifluorometila, C~ 1~-C~ 4~ alcoxi, amino, ciano ou nitro, e pode conter 1 átomo de nitrogênio, ou a um anel de 5 ou 6 membros que pode conter 1-2 átomos de oxigênio, A representa NH ou um átomo de oxigênio, Y é CH~ 2~, CH~ 2~-CH~ 2~, CH~ 2~-CH~ 2~-CH~ 2~, ou CH~ 2-~CH, Z representa um átomo de nitrogênio, átomo de carbono ou CH, sendo possível para a ligação entre Y e Z ser também dupla, e n é o número 2, 3 ou 4. A invenção também se refere aos sais fisiologicamente compatíveis dos derivados inventivos de d3-substituído 3,4 diidro-tieno[2, 3-d]pirimidina.
BR9810017-3A 1997-06-13 1998-05-29 Derivado de 3--substituìdo 3,4-diidrotieno [2, 3d] pirimidina, e, uso do mesmo BR9810017A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19724980A DE19724980A1 (de) 1997-06-13 1997-06-13 3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung
PCT/EP1998/003230 WO1998056792A1 (de) 1997-06-13 1998-05-29 3-substituierte 3,4-dihydro-thieno[2,3-d]pyrimidin-derivate, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
BR9810017A true BR9810017A (pt) 2000-09-19

Family

ID=7832352

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810017-3A BR9810017A (pt) 1997-06-13 1998-05-29 Derivado de 3--substituìdo 3,4-diidrotieno [2, 3d] pirimidina, e, uso do mesmo

Country Status (25)

Country Link
US (1) US6159962A (pt)
EP (1) EP0988306B1 (pt)
JP (1) JP2002504103A (pt)
KR (1) KR20010013696A (pt)
CN (1) CN1260797A (pt)
AR (1) AR015712A1 (pt)
AT (1) ATE244720T1 (pt)
AU (1) AU749320B2 (pt)
BG (1) BG103900A (pt)
BR (1) BR9810017A (pt)
CA (1) CA2293816A1 (pt)
CO (1) CO4940507A1 (pt)
CZ (1) CZ290464B6 (pt)
DE (2) DE19724980A1 (pt)
HR (1) HRP980319A2 (pt)
HU (1) HUP0002902A3 (pt)
ID (1) ID23421A (pt)
IL (1) IL132967A0 (pt)
NO (1) NO996043L (pt)
NZ (1) NZ502238A (pt)
PL (1) PL337453A1 (pt)
SK (1) SK168499A3 (pt)
TR (1) TR199903062T2 (pt)
WO (1) WO1998056792A1 (pt)
ZA (1) ZA985121B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK285198B6 (sk) * 1997-10-27 2006-08-03 Neurosearch A/S Homopiperazínový derivát, farmaceutická kompozícia obsahujúca tento derivát a jeho použitie
DE19900545A1 (de) * 1999-01-11 2000-07-13 Basf Ag Verwendung von Pyrimidinderivaten zur Prophylaxe und Therapie der zerebralen Ischämie
EP1266898A4 (en) * 2000-02-29 2003-05-21 Takeda Chemical Industries Ltd PROCESSES FOR PRODUCING THIENOPYRAMIDINE DERIVATIVES
DE10031389A1 (de) * 2000-07-03 2002-01-17 Knoll Ag Pyrimidinderivate und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie
DE10259382A1 (de) * 2002-12-18 2004-07-01 Abbott Gmbh & Co. Kg 3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-4-on-Derivate, ihre Herstellung und Verwendung
US7612078B2 (en) * 2003-03-31 2009-11-03 Epix Delaware, Inc. Piperidinylamino-thieno[2,3-D] pyrimidine compounds
WO2004089312A2 (en) * 2003-03-31 2004-10-21 Predix Pharmaceuticals Holdings, Inc. New piperidinylamino-thieno[2,3-d] pyrimidine compounds
US20050222175A1 (en) * 2004-03-31 2005-10-06 Dhanoa Dale S New piperidinylamino-thieno[2,3-D] pyrimidine compounds
US7488736B2 (en) * 2004-05-17 2009-02-10 Epix Delaware, Inc. Thienopyridinone compounds and methods of treatment
US7576211B2 (en) * 2004-09-30 2009-08-18 Epix Delaware, Inc. Synthesis of thienopyridinone compounds and related intermediates
US7407966B2 (en) * 2004-10-07 2008-08-05 Epix Delaware, Inc. Thienopyridinone compounds and methods of treatment
US7598265B2 (en) * 2004-09-30 2009-10-06 Epix Delaware, Inc. Compositions and methods for treating CNS disorders
EP2010505B1 (en) 2006-03-28 2012-12-05 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
EP2896624B1 (en) * 2007-03-28 2016-07-13 Atir Holding S.A. Heterotricyclic compounds as serotonergic and/or dopaminergic agents and uses thereof
WO2008138126A1 (en) * 2007-05-09 2008-11-20 Neuromed Pharmaceuticals Ltd. Bicyclic pyrimidine derivatives as calcium channel blockers
WO2010065743A2 (en) * 2008-12-03 2010-06-10 Nanotherapeutics, Inc. Bicyclic compounds and methods of making and using same
US8927718B2 (en) 2009-08-26 2015-01-06 Takeda Pharmaceutical Company Limited Fused heterocyclic ring derivative and use thereof
WO2012140642A1 (en) 2011-04-10 2012-10-18 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
US9671052B2 (en) 2015-10-27 2017-06-06 Whirlpool Corporation Collet securing device for joining two fluid lines and providing lateral support at the connection of the two fluid lines
US10557469B2 (en) 2016-03-22 2020-02-11 Whirlpool Corporation Multi-outlet fluid flow system for an appliance incorporating a bi-directional motor
US10655266B2 (en) 2016-11-30 2020-05-19 Whirlpool Corporation Lint processing fluid pump for a laundry appliance
US10480117B2 (en) 2017-02-27 2019-11-19 Whirlpool Corporation Self cleaning sump cover
US10662574B2 (en) 2017-02-27 2020-05-26 Whirlpool Corporation Self cleaning heater exchanger plate
US10619289B2 (en) 2017-02-27 2020-04-14 Whirlpool Corporation Self cleaning diverter valve
US10634412B2 (en) 2017-04-10 2020-04-28 Whirlpool Corporation Concealed upstream air tower guide vanes
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
US4835157A (en) * 1988-03-15 1989-05-30 Ortho Pharmaceutical Corporation Thieno- and furopyrimidine-2,4-dione piperidine derivatives as serotonin antagonists and alpha adrenergic blocking agents
DE19636769A1 (de) * 1996-09-10 1998-03-12 Basf Ag 3-Substituierte Pyrido [4',3':4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
BG103900A (en) 2000-06-30
US6159962A (en) 2000-12-12
DE19724980A1 (de) 1998-12-17
CO4940507A1 (es) 2000-07-24
WO1998056792A1 (de) 1998-12-17
PL337453A1 (en) 2000-08-14
AU749320B2 (en) 2002-06-20
ATE244720T1 (de) 2003-07-15
TR199903062T2 (xx) 2000-06-21
AU7917698A (en) 1998-12-30
ZA985121B (en) 1999-12-13
HUP0002902A2 (hu) 2001-02-28
NO996043D0 (no) 1999-12-08
DE59808992D1 (de) 2003-08-14
CZ290464B6 (cs) 2002-07-17
SK168499A3 (en) 2000-05-16
ID23421A (id) 2000-04-20
IL132967A0 (en) 2001-03-19
EP0988306A1 (de) 2000-03-29
CZ443199A3 (cs) 2000-06-14
CA2293816A1 (en) 1998-12-17
NZ502238A (en) 2001-02-23
CN1260797A (zh) 2000-07-19
AR015712A1 (es) 2001-05-16
HRP980319A2 (en) 1999-04-30
HUP0002902A3 (en) 2002-09-30
JP2002504103A (ja) 2002-02-05
KR20010013696A (ko) 2001-02-26
NO996043L (no) 1999-12-08
EP0988306B1 (de) 2003-07-09

Similar Documents

Publication Publication Date Title
BR9810017A (pt) Derivado de 3--substituìdo 3,4-diidrotieno [2, 3d] pirimidina, e, uso do mesmo
BRPI0414450A (pt) derivados de diazabicicloalcano substituìdos como ligandos nos receptores de alfa 7 acetilcolina nicotìnica
NZ513561A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
NO983970L (no) Tricykliske forbindelser, deres fremstilling og anvendelse
DK7280A (da) Fremgangsmaade til fremstilling af (piperidinylalkyl) quinazolin-derivater
ATE184000T1 (de) 2-oxindolderivate als tyrosinekinaseinhibitoren
BG104112A (en) 1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them
KR950031113A (ko) 약리학적 활성이 있는 피롤로피리미딘 유도체
AR023681A1 (es) Derivados de tetrahidrobenzazepinas, composiciones farmaceuticas y el uso de los mismos para la manufactura de un medicamento.
EP0282971A3 (en) Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
AR013078A1 (es) Derivados de tetrahidroisoquinoleina, una sal de los mismos, procedimiento para su preparacion, composicion farmaceutica que los comprende y el uso de losmismos en la preparacion de un medicamento.
ES8802517A1 (es) Un procedimiento para preparar fenoxialquil (substituido con heterocido)-isoxazoles y furanos.
CO5271675A1 (es) Derivados de decahidro-isoquinolinas, proceso para su preparacion, composicion y compuestos farmaceuticos que los contienen
ES8404990A1 (es) Un procedimiento para la preparacion de derivados de prolina.
RU99106781A (ru) 3-замещенные производные пиридо[4',3':4,5]тиено[2,3-альфа]пиримидина, их получение и применение
BR9913405A (pt) Composto heterocìclico que contenha oxigênio, e, inibidor de fosfodiesterase (pde) iv.
MXPA02004448A (es) Derivados de imidazopiridina como inhibidores de la fosfodiesterasa vii.
AR008291A1 (es) Derivados de tetrahidroisoquinolina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y su uso para la preparacionde un medicamento.
MX9605366A (es) Derivados de amidina biciclicos como inhibidores de la oxido nitrico sintetasa.
HUP0003942A2 (hu) Helyettesített 3,3-diamino-2-propén-nitrilek, előállításuk és alkalmazásuk
KR910007928A (ko) 신규 벤조[1,8] 나프티리딘 유도체, 그의 제조 및 그를 함유하는 조성물
ES8800937A1 (es) Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES2039221T3 (es) Procedimiento para producir derivados de piridazinona.
BR0004548A (pt) Derivados i de quinolin-4-ila
IL89156A (en) Derivatives of 2-((4-piperidinyl) methyl)- 1,2,3,4- tetrahydroisoquinoline, their preparation and their application in therapeutics

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A,8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.